Both in Pharmaceuticals
Vertex Pharmaceuticals vs Regeneron Pharmaceuticals
Over the past year VRTX returned +31.2% and REGN returned +44.5%; their daily moves had a correlation of 0.46.
VRTX +31.2% REGN +44.5%Growth of $1, one year, split-adjusted
| Metric | VRTX | REGN |
|---|---|---|
| Price | $558.88 | $927.89 |
| Market cap | $141.65B | $95.99B |
| Today | +3.50% | +13.33% |
| 1 month | +10.3% | +26.3% |
| 6 months | +31.8% | +32.3% |
| Year to date | +23.3% | +20.2% |
| 1 year | +34.0% | +42.1% |
| Revenue growth (YoY) | +12.5% | +36.3% |
| Gross margin | 85.3% | 88.8% |
| Net margin | 33.0% | 38.1% |
| P/E (TTM) | 32.2× | 19.9× |
| Price / sales | 11.3× | 5.7× |
| Net cash | $7.85B | $6.59B |
| Dividend yield | — | 0.41% |
| Volatility (60d) | 28.7% | 37.0% |
| Short % of float | 1.7% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).